Symbols / BNTC $13.33 +1.14% Benitec Biopharma Inc.

Healthcare • Biotechnology • United States • NCM
BNTC Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.

Fundamentals
Scroll to Statements
Market Cap 456.62M Enterprise Value 264.99M Income -44.11M Sales — Book/sh 5.47 Cash/sh 5.50
Dividend Yield — Payout — Employees 19 IPO — P/E — Forward P/E -1.42
PEG — P/S — P/B 2.44 P/C — EV/EBITDA -5.49 EV/Sales —
Quick Ratio 67.45 Current Ratio 67.69 Debt/Eq 0.53 LT Debt/Eq — EPS (ttm) -1.08 EPS next Y -9.42
EPS Growth — Revenue Growth — Earnings 2026-05-14 ROA -22.41% ROE -33.50% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 34.25M Shs Float 17.83M Short Float 11.88%
Short Ratio 10.98 Short Interest — 52W High 17.15 52W Low 9.85 Beta 0.12 Avg Volume 158.56K
Volume 61.70K Target Price $24.17 Recom Strong_buy Prev Close $13.18 Price $13.33 Change 1.14%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$24.17
Mean price target
2. Current target
$12.96
Latest analyst target
3. DCF / Fair value
$-2.29
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$12.96
Low
$17.00
High
$32.00
Mean
$24.17

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-09 reit HC Wainwright & Co. Buy → Buy $32
2025-11-24 main HC Wainwright & Co. Buy → Buy $32
2025-11-04 main HC Wainwright & Co. Buy → Buy $35
2025-11-04 main Citizens Market Outperform → Market Outperform $22
2025-09-24 reit JMP Securities Market Outperform → Market Outperform $20
2025-09-16 main Oppenheimer Outperform → Outperform $29
2025-05-19 reit HC Wainwright & Co. Buy → Buy $28
2025-05-15 reit JMP Securities Market Outperform → Market Outperform $20
2025-04-10 main JMP Securities Market Outperform → Market Outperform $20
2025-03-24 reit HC Wainwright & Co. Buy → Buy $28
2025-03-18 reit Citizens Capital Markets Market Outperform → Market Outperform $18
2025-02-21 reit HC Wainwright & Co. Buy → Buy $28
2024-12-13 init Baird — → Outperform $30
2024-12-03 reit Guggenheim Buy → Buy $17
2024-07-22 init Leerink Partners — → Outperform $13
2024-06-13 init Piper Sandler — → Overweight $30
2024-04-22 main JMP Securities Market Outperform → Market Outperform $16
2024-02-15 main JMP Securities Market Outperform → Market Outperform $10
2024-01-24 main JMP Securities Market Outperform → Market Outperform $8
2023-09-26 main JMP Securities Market Outperform → Market Outperform $6
News
RSS: Latest BNTC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-29 SUVRETTA CAPITAL MANAGEMENT, LLC Beneficial Owner of more than 10% of a Class of Security — 144,223 $12.85 $1,903,133
2025-12-22 SUVRETTA CAPITAL MANAGEMENT, LLC Beneficial Owner of more than 10% of a Class of Security — 46,141 $11.24 $538,972
2025-11-07 SUVRETTA CAPITAL MANAGEMENT, LLC Director and Beneficial Owner of more than 10% of a Class of Security — 1,481,481 $13.50 $19,999,994
2025-03-31 SUVRETTA CAPITAL MANAGEMENT, LLC Beneficial Owner of more than 10% of a Class of Security — 16,497 $12.63 $211,736
2025-03-26 SUVRETTA CAPITAL MANAGEMENT, LLC Beneficial Owner of more than 10% of a Class of Security — 900,000 $13.00 $11,700,000
2025-03-12 BUCHI J. KEVIN Director — 103,626 $0.00 $0
2025-02-27 BUCHI J. KEVIN Director — 51,813 $3.86 $199,998
2024-12-24 SUVRETTA CAPITAL MANAGEMENT, LLC Director and Beneficial Owner of more than 10% of a Class of Security — 47,520 $10.98 $527,174
2024-12-03 SUVRETTA CAPITAL MANAGEMENT, LLC Director and Beneficial Owner of more than 10% of a Class of Security — 42,000 $9.60 $403,200
2024-11-20 SUVRETTA CAPITAL MANAGEMENT, LLC Director and Beneficial Owner of more than 10% of a Class of Security — 41,436 $9.73 $416,616
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
0.00
0.00
-100.00%
0.07
+2.74%
0.07
Operating Revenue
0.00
0.00
-100.00%
0.07
+2.74%
0.07
Cost Of Revenue
—
—
0.00
-100.00%
0.01
Reconciled Cost Of Revenue
—
—
0.00
-100.00%
0.01
Gross Profit
—
—
0.07
+17.19%
0.06
Operating Expense
41.77
+85.70%
22.49
+17.40%
19.16
+6.91%
17.92
Research And Development
18.33
+17.45%
15.61
+22.19%
12.77
+13.33%
11.27
Selling General And Administration
23.43
+235.28%
6.99
+9.51%
6.38
-3.97%
6.65
General And Administrative Expense
23.43
+235.28%
6.99
+9.51%
6.38
-3.97%
6.65
Salaries And Wages
—
—
0.29
-52.53%
0.61
Other Gand A
23.43
+235.28%
6.99
+9.51%
6.38
-3.97%
6.65
Other Operating Expenses
—
-0.11
—
0.01
Total Expenses
41.77
+85.70%
22.49
+17.40%
19.16
+6.86%
17.93
Operating Income
-41.77
-85.70%
-22.49
-17.87%
-19.08
-6.87%
-17.85
Total Operating Income As Reported
-41.77
-85.70%
-22.49
-17.87%
-19.08
-6.87%
-17.85
EBITDA
-41.37
-86.79%
-22.15
-18.43%
-18.70
-5.15%
-17.78
Normalized EBITDA
-42.06
-89.59%
-22.19
-21.35%
-18.28
-4.22%
-17.54
Reconciled Depreciation
0.40
+15.45%
0.34
-9.97%
0.38
-2.81%
0.39
EBIT
-41.77
-85.70%
-22.49
-17.87%
-19.08
-4.98%
-18.18
Total Unusual Items
0.69
+1676.92%
0.04
+109.33%
-0.42
-72.02%
-0.24
Total Unusual Items Excluding Goodwill
0.69
+1676.92%
0.04
+109.33%
-0.42
-72.02%
-0.24
Special Income Charges
0.76
0.00
—
—
Other Special Charges
-0.76
—
—
—
Net Income
-37.92
-74.32%
-21.75
-11.19%
-19.56
-7.44%
-18.21
Pretax Income
-37.92
-74.32%
-21.75
-11.19%
-19.56
-7.44%
-18.21
Net Non Operating Interest Income Expense
3.29
+263.50%
0.90
+2839.39%
-0.03
-3.13%
-0.03
Interest Expense Non Operating
—
—
0.03
+3.13%
0.03
Net Interest Income
3.29
+263.50%
0.90
+2839.39%
-0.03
-3.13%
-0.03
Interest Expense
—
—
0.03
+3.13%
0.03
Interest Income Non Operating
—
—
—
—
Interest Income
—
—
—
—
Other Income Expense
0.56
+440.61%
-0.17
+63.17%
-0.45
-39.13%
-0.32
Other Non Operating Income Expenses
-0.13
+35.78%
-0.20
-580.00%
-0.03
+62.03%
-0.08
Gain On Sale Of Security
-0.07
-282.05%
0.04
+109.33%
-0.42
-72.02%
-0.24
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-37.92
-74.32%
-21.75
-11.19%
-19.56
-7.44%
-18.21
Net Income From Continuing Operation Net Minority Interest
-37.92
-74.32%
-21.75
-11.19%
-19.56
-7.44%
-18.21
Net Income From Continuing And Discontinued Operation
-37.92
-74.32%
-21.75
-11.19%
-19.56
-7.44%
-18.21
Net Income Continuous Operations
-37.92
-74.32%
-21.75
-11.19%
-19.56
-7.44%
-18.21
Normalized Income
-38.61
-77.19%
-21.79
-13.82%
-19.14
-6.56%
-17.96
Net Income Common Stockholders
-37.92
-69.50%
-22.37
-14.35%
-19.56
-7.44%
-18.21
Otherunder Preferred Stock Dividend
0.00
-100.00%
0.62
0.00
—
Diluted EPS
-1.05
+13.93%
-1.22
+91.36%
-14.12
+62.75%
-37.91
Basic EPS
-1.05
+13.93%
-1.22
+91.36%
-14.12
+62.75%
-37.91
Basic Average Shares
36.21
+97.17%
18.36
+1225.17%
1.39
+188.30%
0.48
Diluted Average Shares
36.21
+97.17%
18.36
+1225.17%
1.39
+188.30%
0.48
Diluted NI Availto Com Stockholders
-37.92
-69.50%
-22.37
-14.35%
-19.56
-7.44%
-18.21
Total Other Finance Cost
-3.29
-263.50%
-0.90
-2839.39%
0.03
—
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Assets
99.59
+90.75%
52.21
+1069.58%
4.46
-25.26%
5.97
Current Assets
98.52
+90.65%
51.67
+1285.73%
3.73
-22.63%
4.82
Cash Cash Equivalents And Short Term Investments
97.74
+92.16%
50.87
+1953.53%
2.48
-39.02%
4.06
Cash And Cash Equivalents
97.74
+92.16%
50.87
+1953.53%
2.48
-39.02%
4.06
Cash Equivalents
—
—
—
—
Cash Financial
97.74
+92.16%
50.87
+1953.53%
2.48
-39.02%
4.06
Receivables
0.03
-85.59%
0.23
+316.36%
0.06
+1733.33%
0.00
Accounts Receivable
0.03
-85.59%
0.23
+316.36%
0.06
+1733.33%
0.00
Prepaid Assets
—
—
—
0.74
Restricted Cash
0.11
+79.37%
0.06
+384.62%
0.01
-7.14%
0.01
Other Current Assets
0.63
+21.71%
0.52
-56.42%
1.18
+59.78%
0.74
Total Non Current Assets
1.07
+100.37%
0.54
-27.07%
0.73
-36.25%
1.15
Net PPE
0.99
+120.71%
0.45
-26.75%
0.61
-38.27%
0.99
Gross PPE
2.46
+32.81%
1.85
-4.04%
1.93
-11.22%
2.17
Accumulated Depreciation
-1.47
-4.70%
-1.40
-6.53%
-1.32
-11.51%
-1.18
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
0.86
+218.52%
0.27
-48.67%
0.53
-31.78%
0.77
Machinery Furniture Equipment
0.04
+15.79%
0.04
+0.00%
0.04
+2.70%
0.04
Other Properties
1.53
+0.79%
1.52
+13.25%
1.34
+0.00%
1.34
Leases
0.02
+0.00%
0.02
+0.00%
0.02
+0.00%
0.02
Non Current Prepaid Assets
0.08
-4.60%
0.09
+248.00%
0.03
+0.00%
0.03
Other Non Current Assets
—
0.06
-36.08%
0.10
-28.15%
0.14
Total Liabilities Net Minority Interest
2.30
-53.71%
4.96
+16.42%
4.26
+37.88%
3.09
Current Liabilities
1.80
-63.40%
4.92
+23.78%
3.98
+57.11%
2.53
Payables And Accrued Expenses
1.02
-75.46%
4.17
+28.91%
3.23
+71.86%
1.88
Payables
0.27
-82.00%
1.49
+23.16%
1.21
+145.23%
0.49
Accounts Payable
0.20
-85.12%
1.35
+18.51%
1.14
+170.14%
0.42
Other Payable
0.07
-51.45%
0.14
+100.00%
0.07
-2.82%
0.07
Current Accrued Expenses
0.75
-71.82%
2.68
+32.34%
2.02
+45.78%
1.39
Employee Benefits
0.00
-100.00%
0.04
—
—
Pensionand Other Post Retirement Benefit Plans Current
0.43
-10.32%
0.47
+0.64%
0.47
+18.00%
0.40
Current Debt And Capital Lease Obligation
0.35
+24.65%
0.28
+3.27%
0.28
+9.13%
0.25
Current Capital Lease Obligation
0.35
+24.65%
0.28
+3.27%
0.28
+9.13%
0.25
Total Non Current Liabilities Net Minority Interest
0.49
+1202.63%
0.04
-86.62%
0.28
-49.19%
0.56
Long Term Debt And Capital Lease Obligation
0.49
0.00
-100.00%
0.28
-49.19%
0.56
Long Term Capital Lease Obligation
0.49
0.00
-100.00%
0.28
-49.19%
0.56
Long Term Provisions
—
0.04
—
—
Stockholders Equity
97.30
+105.92%
47.25
+23290.10%
0.20
-92.99%
2.88
Common Stock Equity
97.30
+105.92%
47.25
+23290.10%
0.20
-92.99%
2.88
Capital Stock
0.00
+100.00%
0.00
0.00
0.00
Common Stock
0.00
+100.00%
0.00
0.00
0.00
Preferred Stock
0.00
0.00
—
—
Share Issued
26.25
+160.26%
10.09
+512.78%
1.65
+242.42%
0.48
Ordinary Shares Number
26.25
+160.26%
10.09
+512.78%
1.65
+242.42%
0.48
Additional Paid In Capital
326.31
+36.88%
238.40
+41.13%
168.92
+10.80%
152.45
Retained Earnings
-228.18
-19.93%
-190.26
-13.32%
-167.89
-13.19%
-148.33
Gains Losses Not Affecting Retained Earnings
-0.84
+5.94%
-0.89
-7.47%
-0.83
+33.33%
-1.25
Other Equity Adjustments
-0.84
+5.94%
-0.89
-7.47%
-0.83
+33.33%
-1.25
Total Equity Gross Minority Interest
97.30
+105.92%
47.25
+23290.10%
0.20
-92.99%
2.88
Total Capitalization
97.30
+105.92%
47.25
+23290.10%
0.20
-92.99%
2.88
Working Capital
96.72
+106.88%
46.75
+18875.10%
-0.25
-110.88%
2.29
Invested Capital
97.30
+105.92%
47.25
+23290.10%
0.20
-92.99%
2.88
Total Debt
0.85
+198.94%
0.28
-49.19%
0.56
-31.07%
0.81
Capital Lease Obligations
0.85
+198.94%
0.28
-49.19%
0.56
-31.07%
0.81
Net Tangible Assets
97.30
+105.92%
47.25
+23290.10%
0.20
-92.99%
2.88
Tangible Book Value
97.30
+105.92%
47.25
+23290.10%
0.20
-92.99%
2.88
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
-23.59
-21.57%
-19.40
-7.72%
-18.01
-13.29%
-15.90
Cash Flow From Continuing Operating Activities
-23.59
-21.57%
-19.40
-7.72%
-18.01
-13.29%
-15.90
Net Income From Continuing Operations
-37.92
-74.32%
-21.75
-11.19%
-19.56
-7.44%
-18.21
Depreciation Amortization Depletion
0.40
+15.45%
0.34
-9.97%
0.38
-2.81%
0.39
Depreciation
0.40
+15.45%
0.34
-9.97%
0.38
-2.81%
0.39
Depreciation And Amortization
0.40
+15.45%
0.34
-9.97%
0.38
-2.81%
0.39
Other Non Cash Items
-0.76
—
—
—
Stock Based Compensation
17.43
+1999.52%
0.83
+83.63%
0.45
-48.05%
0.87
Unrealized Gain Loss On Investment Securities
0.00
-100.00%
0.00
-66.67%
0.00
-70.00%
0.01
Gain Loss On Sale Of PPE
—
—
—
—
Change In Working Capital
-2.73
-332.45%
1.17
+64.43%
0.71
-31.15%
1.04
Change In Receivables
0.20
+211.93%
-0.18
-252.00%
-0.05
-5100.00%
0.00
Change In Prepaid Assets
-0.11
-117.21%
0.65
+255.80%
-0.41
-767.74%
0.06
Change In Payables And Accrued Expense
-2.46
-350.92%
0.98
-31.47%
1.43
+31.19%
1.09
Change In Accrued Expense
-0.08
-307.69%
0.04
-46.58%
0.07
—
Change In Payable
-2.38
-352.71%
0.94
-30.66%
1.36
+24.50%
1.09
Change In Other Working Capital
—
—
0.07
-8.75%
0.08
Change In Other Current Liabilities
-0.36
-29.45%
-0.28
-9.13%
-0.25
-28.57%
-0.20
Investing Cash Flow
-0.02
+89.94%
-0.18
-17800.00%
-0.00
+92.31%
-0.01
Cash Flow From Continuing Investing Activities
-0.02
+89.94%
-0.18
-17800.00%
-0.00
+92.31%
-0.01
Net PPE Purchase And Sale
-0.02
+89.94%
-0.18
-17800.00%
-0.00
+92.31%
-0.01
Purchase Of PPE
-0.02
+89.94%
-0.18
-17800.00%
-0.00
+92.31%
-0.01
Sale Of PPE
—
—
—
—
Capital Expenditure
-0.02
+89.94%
-0.18
-17800.00%
-0.00
+92.31%
-0.01
Financing Cash Flow
70.48
+3.61%
68.03
+324.78%
16.02
0.00
Cash Flow From Continuing Financing Activities
70.48
+3.61%
68.03
+324.78%
16.02
0.00
Net Common Stock Issuance
30.46
-57.03%
70.88
+296.35%
17.88
0.00
Proceeds From Stock Option Exercised
42.34
+1293.81%
3.04
—
—
Net Other Financing Charges
-2.32
+60.64%
-5.89
-215.25%
-1.87
—
Changes In Cash
46.88
-3.24%
48.45
+2524.77%
-2.00
+87.44%
-15.91
Effect Of Exchange Rate Changes
0.05
+712.50%
-0.01
-101.94%
0.41
+101.96%
0.20
Beginning Cash Position
50.93
+1945.34%
2.49
-38.91%
4.08
-79.40%
19.78
End Cash Position
97.86
+92.14%
50.93
+1945.34%
2.49
-38.91%
4.08
Free Cash Flow
-23.61
-20.55%
-19.58
-8.71%
-18.01
-13.20%
-15.91
Common Stock Issuance
30.46
-57.03%
70.88
+296.35%
17.88
0.00
Issuance Of Capital Stock
30.46
-57.03%
70.88
+296.35%
17.88
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category